Highly active compounds against COVID-19
US12226429B2 · kind B2 · utility
0Cited by
200References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2023 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Jul 24, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/207
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is the use of a small group of purine nucleotide phosphoramidate disclosed herein or a pharmaceutically acceptable salt thereof in an effective amount for the treatment or prevention of the novel 2019 coronavirus disease (COVID-19) in a host, for example a human, in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.